BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11152481)

  • 1. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
    Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
    J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the p53 core domain dimer bound to DNA.
    Ho WC; Fitzgerald MX; Marmorstein R
    J Biol Chem; 2006 Jul; 281(29):20494-502. PubMed ID: 16717092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA.
    Klein C; Planker E; Diercks T; Kessler H; Künkele KP; Lang K; Hansen S; Schwaiger M
    J Biol Chem; 2001 Dec; 276(52):49020-7. PubMed ID: 11606582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the human p53 core domain in the absence of DNA.
    Wang Y; Rosengarth A; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.
    Calhoun S; Daggett V
    Biochemistry; 2011 Jun; 50(23):5345-53. PubMed ID: 21561095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    Joerger AC; Allen MD; Fersht AR
    J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds.
    Ho WC; Luo C; Zhao K; Chai X; Fitzgerald MX; Marmorstein R
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1484-93. PubMed ID: 17139084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.
    Chen Y; Dey R; Chen L
    Structure; 2010 Feb; 18(2):246-56. PubMed ID: 20159469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent and active p53 are identical in conformation.
    Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
    Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling multi-component protein-DNA complexes: the role of bending and dimerization in the complex of p53 dimers with DNA.
    Lebrun A; Lavery R; Weinstein H
    Protein Eng; 2001 Apr; 14(4):233-43. PubMed ID: 11391015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
    Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
    Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a multidomain human p53 tetramer bound to the natural CDKN1A (p21) p53-response element.
    Emamzadah S; Tropia L; Halazonetis TD
    Mol Cancer Res; 2011 Nov; 9(11):1493-9. PubMed ID: 21933903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex.
    Tidow H; Melero R; Mylonas E; Freund SM; Grossmann JG; Carazo JM; Svergun DI; Valle M; Fersht AR
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12324-9. PubMed ID: 17620598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.